Correlation Between Xinjiang Tianshun and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xinjiang Tianshun and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xinjiang Tianshun and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xinjiang Tianshun Supply and Innovative Medical Management, you can compare the effects of market volatilities on Xinjiang Tianshun and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xinjiang Tianshun with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xinjiang Tianshun and Innovative Medical.

Diversification Opportunities for Xinjiang Tianshun and Innovative Medical

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Xinjiang and Innovative is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Xinjiang Tianshun Supply and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Xinjiang Tianshun is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xinjiang Tianshun Supply are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Xinjiang Tianshun i.e., Xinjiang Tianshun and Innovative Medical go up and down completely randomly.

Pair Corralation between Xinjiang Tianshun and Innovative Medical

Assuming the 90 days trading horizon Xinjiang Tianshun Supply is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Xinjiang Tianshun Supply is 1.15 times less risky than Innovative Medical. The stock trades about -0.01 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  713.00  in Innovative Medical Management on September 6, 2024 and sell it today you would earn a total of  180.00  from holding Innovative Medical Management or generate 25.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.79%
ValuesDaily Returns

Xinjiang Tianshun Supply  vs.  Innovative Medical Management

 Performance 
       Timeline  
Xinjiang Tianshun Supply 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Xinjiang Tianshun Supply are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Xinjiang Tianshun sustained solid returns over the last few months and may actually be approaching a breakup point.
Innovative Medical 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Xinjiang Tianshun and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xinjiang Tianshun and Innovative Medical

The main advantage of trading using opposite Xinjiang Tianshun and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xinjiang Tianshun position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Xinjiang Tianshun Supply and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation